Anca Safta to Treatment Outcome
This is a "connection" page, showing publications Anca Safta has written about Treatment Outcome.
Connection Strength
0.060
-
Jensen ET, Huang KZ, Chen HX, Landes LE, McConnell KA, Almond MA, Safta AM, Johnston DT, Durban R, Jobe L, Frost C, Donnelly S, Antonio B, Quiros A, Markowitz JE, Dellon ES. Longitudinal Growth Outcomes Following First-line Treatment for Pediatric Patients With Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr. 2019 01; 68(1):50-55.
Score: 0.025
-
Reed CC, Safta AM, Qasem S, Angie Almond M, Dellon ES, Jensen ET. Combined and Alternating Topical Steroids and Food Elimination Diet for the Treatment of Eosinophilic Esophagitis. Dig Dis Sci. 2018 09; 63(9):2381-2388.
Score: 0.023
-
Davies YK, Cox KM, Abdullah BA, Safta A, Terry AB, Cox KL. Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic. J Pediatr Gastroenterol Nutr. 2008 Jul; 47(1):61-7.
Score: 0.012